Peregrine X Ltd 13986143 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is that of a production holding company. Digita Accounts Production Advanced 6.30.9574.0 true false true false 13986143 2023-04-01 2024-03-31 13986143 2024-03-31 13986143 bus:OrdinaryShareClass1 2024-03-31 13986143 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13986143 core:Non-currentFinancialInstruments 2024-03-31 13986143 bus:SmallEntities 2023-04-01 2024-03-31 13986143 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13986143 bus:AbridgedAccounts 2023-04-01 2024-03-31 13986143 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13986143 bus:RegisteredOffice 2023-04-01 2024-03-31 13986143 bus:Director1 2023-04-01 2024-03-31 13986143 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 13986143 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13986143 core:Subsidiary1 2023-04-01 2024-03-31 13986143 core:Subsidiary1 1 2023-04-01 2024-03-31 13986143 core:Subsidiary1 countries:AllCountries 2023-04-01 2024-03-31 13986143 countries:AllCountries 2023-04-01 2024-03-31 13986143 2023-03-31 13986143 core:CostValuation core:Non-currentFinancialInstruments 2023-03-31 13986143 2022-03-18 2023-03-31 13986143 2023-03-31 13986143 bus:OrdinaryShareClass1 2023-03-31 13986143 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 13986143 core:Non-currentFinancialInstruments 2023-03-31 13986143 core:Subsidiary1 1 2022-03-18 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 13986143

Peregrine X Ltd

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

Peregrine X Ltd

Contents

Abridged Balance Sheet

1 to 2

Notes to the Unaudited Abridged Financial Statements

3 to 6

 

Peregrine X Ltd

(Registration number: 13986143)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

164,982

68,723

Investments

5

9,500,100

9,500,100

 

9,665,082

9,568,823

Current assets

 

Cash at bank and in hand

 

97,101

30,053

Prepayments and accrued income

 

1,279

6,173

Creditors: Amounts falling due within one year

(7,117)

(2,360)

Net current assets

 

91,263

33,866

Total assets less current liabilities

 

9,756,345

9,602,689

Accruals and deferred income

 

(3,000)

(4,000)

Net assets

 

9,753,345

9,598,689

Capital and reserves

 

Called up share capital

6

10,000

10,000

Share premium reserve

11,187,437

10,564,449

Retained earnings

(1,444,092)

(975,760)

Shareholders' funds

 

9,753,345

9,598,689

 

Peregrine X Ltd

(Registration number: 13986143)
Abridged Balance Sheet as at 31 March 2024

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 9 May 2024 and signed on its behalf by:
 

.........................................
Mr J Last
Director

 

Peregrine X Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
London Bioscience Innovation Centre
2 Royal College Street
London
NW1 0NH

These financial statements were authorised for issue by the Board on 9 May 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Group accounts not prepared

The company is part of a small group. The company has taken advantage of the exemption provided by Section 398 of the Companies Act 2006 and has not prepared group accounts..

Going concern

The financial statements have been prepared on a going concern basis.

Intangible assets

Separately acquired intangible assets are shown at historical cost.

Investments

Investments in equity shares where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Peregrine X Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 1).

 

Peregrine X Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

4

Intangible assets

Total
£

Cost

At 1 April 2023

68,723

Additions acquired separately

96,259

At 31 March 2024

164,982

Amortisation

Carrying amount

At 31 March 2024

164,982

At 31 March 2023

68,723

5

Investments

Total
£

Valuation

At 1 April 2023

9,500,100

Provision

Carrying amount

At 31 March 2024

9,500,100

At 31 March 2023

9,500,100

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2024

2023

Subsidiary undertakings

Peregrine Analytics Limited

London Bioscience Innovation Centre
2 Royal College Street
London
NW1 0NH

England & Wales

Ordinary

100%

100%

 

Peregrine X Ltd

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Subsidiary undertakings

Peregrine Analytics Limited

The principal activity of Peregrine Analytics Limited is the provision of analytical solutions for oil, water and blood samples but is now a dormant company.

6

Share capital

Allotted, called up and fully paid shares

 

2024

2023

 

No.

£

No.

£

Ordinary shares of £0.00 each

100,000,000

10,000

100,000,000

10,000